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model (HMM) algorithms, PennCNV and QuantiSNP, which call CNVs based on logR ratio 
and B allele frequency. Deletions and duplications greater than 10 kb were included. 
Common CNVs were excluded. Association testing was performed with 1 million permu-
tations in PLINK. Significant CNVs were confirmed with digital droplet polymerase chain 
reaction (ddPCR). Whole genome sequencing was performed to determine insertion loca-
tion and breakpoints. 
R ESULTS. Esotropia patients have similar rates and proportions of CNVs compared with 
controls but greater total length and average size of both deletions and duplications. 
Three recurrent rare duplications significantly (P = 1 x 10-6) increase the risk of 
esotropia: chromosome 2pll.2 (hg19, 2:87428677-87965359), spanning one long noncod-
ing RNA (IncRNA) and two microRNAs (OR 14.16; 95% confidence interval [CI] 5.4-
38.1); chromosome 4pl5.2 (hg19, 4:25554332-25577184), spanning one lncRNA (OR 11.1; 
95% CI 4.6-25.2); chromosome l0qll.22 (hg19, 10:47049547-47703870) spanning seven 
protein-coding genes, one lncRNA, and four pseudogenes (OR 8.96; 95% CI 5.4-14.9). 
Overall, 114 cases (7%) and only 28 controls (0. 7%) had one of the three rare duplications . 
No case nor control had more than one of these three duplications. 
CoNCLus10Ns. Rare CNVs are a source of genetic variation that contribute to the genetic 
risk for comitant esotropia, which is likely polygenic. Future research into the functional 
consequences of these recurrent duplications may shed light on the pathophysiology of 
esotropia. 
Keywords: esotropia, strabismus, copy number variant, CNV, genetics of strabismus 
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Rare CNVs Increase Risk for Esotropia 
S trabismus affects 2% to 4% of the population and causes amblyopia, loss of binocular vision, and lower quality of 
life.1•2 Strabismus runs in families, and population, family, 
and twin studies support a genetic contribution.3- 5 Twin 
meta-analysis supports a strong genetic contribution,3 partic-
ularly for esodeviations.6 The relative risk for first-degree 
relatives of an affected proband is estimated to be between 3 
and 5_3,5,7- 9 The heritability factor remains significant after 
correction for the known environmental risk factors:5 low 
birth weight, prematurity, maternal smoking, and advanced 
maternal age.10- 17 
Causative genes have been identified for paralytic strabis-
mus syndromes, in which patients cannot fully move their 
eyes.18 In common forms of strabismus, however, no specific 
mutations have been reported, despite reported mapping 
of three Mendelian loci (7p22.1, 4q28.3 and 7q31.2).7•19,20 
We recently completed a genome wide association study 
(GWAS) of non-accommodative esotropia and identified one 
risk allele, an intronic single nucleotide polymorphism (SNP) 
of the WRB gene, which affects ex'Pression of WRB and 
neighboring genes.21 A second GWAS, using self-reported 
strabismus in the UK Biobank, identified a locus on chromo-
some 17q25, which extends across the NPLOC4-TSPANIO-
PDE6G gene cluster.22 This locus has been associated 
through GWAS with several eye conditions, including macu-
lar thickness,23 astigmatism,24 retinal microvascular size,25 
and myopia.26 
Genetic variation can result from DNA sequence differ-
ences, duplications or deletions of genomic elements (copy 
number variants [CNVs)), or complex genetic rearrange-
ments. CNVs can alter gene function, gene dosages, regula-
tory elements, or 3D chromatin structure.27 CNVs have been 
implicated in neurodevelopmental disorders with complex 
inheritance, including autism spectrum disorder,28- 37 intel-
lectual disabiltity,38- 42 and Tourette syndrome.43 Strabismus 
is a neurodevelopmental disorder affecting the neural path-
ways that control ocular alignment and binocular fusion 
and is prevalent in patients with other neurodevelopmental 
disorders. We therefore examined our cohort of individuals 
with isolated esotropia for rare CNVs. We report here on 
three rare, recurrent DNA duplications that increase the risk 
of esotropia. 
METHODS 
This study was approved by the local Institutional Review 
Boards of Boston Children's Hospital, Boston, MA, USA; 
The Cleveland Clinic, Cleveland, OH, USA; Leicestershire, 
Northamptonshire and Rutland Committee for the National 
Research Ethics Service, UK; Rutland Research Ethics 
Committee, UK; Human Research Ethics Committee, Royal 
Victorian Eye and Ear Hospital, East Melbourne, Victo-
ria, Australia; Princess Margaret Hospital, Perth, Western 
Australia; and Sir Charles Gairdner Hospital, Perth, Western 
Australia. Informed consent was obtained from all partici-
pants. All investigations were conducted in accordance with 
the principles of the Declaration of Helsinki. 
Cases 
The esotropia cohort consists of patients from our previous 
GWAS,21 including both accommodative and nonaccom-
modative cases. Inclusion and exclusion criteria were the 
same: manifest or intermittent esotropia of any size, a 
history of strabismus surgery for comitant esotropia, or 
esophoria ~10 prism diopters. Accommodative esotropia 
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was defined as manifest esotropia that reduced with hyper-
opic correction to < 10 prism diopters. Infantile esotropia 
was defined as esotropia with onset before the age of 
12 months. Nonaccommodative esotropia was defined as 
manifest or intermittent esotropia with onset after age 
12 months that did not reduce to <10 prism diopters with 
hyperopic correction; this includes partially accommodative 
esotropia. By definition, fully accommodative cases did not 
have strabismus surgery; any patient who had strabismus 
surgery was classified as either non-accommodative or 
infantile, depending on age of onset. Exclusion criteria 
included structural ocular abnormality causing acquired 
vision loss; structural brain abnormality on neuroimag-
ing; deprivation amblyopia; molecularly defined genetic 
syndromes or diagnoses associated with strabismus, such 
as trisomy 21 or craniosynostosis; or defined nonheritable 
cause of strabismus. A total of 2030 participants who 
self-reported as White of European ancestry (and in whom 
principal component analysis confinned European ances-
try) were enrolled: 1105 from Boston Children's Hospital, 
745 from Australia (private ophthalmologists and public 
hospitals in Victoria, Western Australia, Tasmania, and 
New South Wales), 111 from Leicester, University Hospitals 
of Leicester, UK, 52 from Cole Eye Institute (Cleveland 
Clinic), 5 from Children's Hospital of Philadelphia, and 
12 self-referred. After all quality control filters for CNV 
calling, the total number of participants included was 1614. 
Controls 
Control subjects of Caucasian ancestry were ascertained 
in which participants were genotyped on the Illumina 
Omni platform, and intensity data were available. This 
included controls from the Genomic Psychiatry Cohort 
and publicly-available controls from a GWAS of Fuchs' 
Endothelial Corneal Dystrophy (FECD) (accession number: 
phs000421.vl.pl), derived from the database of Geno-
types and Phenotypes (dbGaP). After all quality control 
filters, 3922 control participants were included. None of the 
controls were reported to have strabismus, although strabis-
mus was not specifically excluded from the ascertainment 
cohorts. 
Genotyping 
Esotropia patients were genotyped on Illumina Infinium 
human OmniExpress-24vl-0 array. Control cohorts from 
FECD were genotyped on Illumina HumanOmni 2.5 Versions 
4v_lH array and the Genomic Psychiatry cohort was geno-
typed on Illumina OmniExpress 12vl.0. 98% of the individ-
ual SNPs present on OmniExpress-24vl-0 are present on 
the other arrays. SNP clustering and genotype calling was 
performed with GenomeStudio v2.0 (Illumina, San Diego, 
CA, USA). Samples with a call rate <0.98 or with discordant 
sex were excluded . 
Intensity Sample Quality Control 
Intensity-based metrics were used to eliminate samples 
unsuitable for CNV calling. These included the following: 
waviness factor (WF)- a measure of the waviness in inten-
sity values, a known artifact caused by improper DNA 
concentration that can lead to spurious calls; Log-R ratio 
standard deviation (LRR_SD)- a measure of the overall vari-
ance in intensity; B allele frequency drift (BAF _DRIFf)-
a summary of the deviation of BAF from expected values. 
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A DELETIONS Affected (1614) Unaffected (3922) p N 1294 3333 B 
DUPLICATIONS Affected (1614) Unaffected (3922) p 
N 1766 4760 
RATE 0.8017 0.8498 0.9559 RATE 1.094 1.214 0.9977 
PROP 0.5378 0.5566 0.9048 PROP 0.6233 0.6254 0.5712 
TOTKB 220.7 177.8 0.0077 TO TKB 419.6 258 lxl~ 
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F1GUR£ 1. Rare CNV burden in esotropia cases and controls. Esotropia cases have similar rates (number per person) and proportions 
(percent of people with at least one) of rare ( < 1% frequency), > 10 kb deletions (A) and duplications (B) to controls. Toe total length and 
average siZe of each CNV, however, are larger in esotropia cases. (C-F) Odds ratios for esotropia given different CNV sizes (C, duplications, 
E, deletions) and frequencies (D, duplications, F, deletions). Duplications of 500 kb-1 MB and greater than 1 MB and deletions > l MB were 
associated with higher risk of esotropia. Frequency of CNVs was not associated with esotropia. • P < 0.015, •• P < 0.0001. 
Cutoff values for each were determined empirically. Samples 
included had LRR-SD of <0.3, absolute value of WF <0.43, 
and BAF_DRIFf <0.01. We eliminated samples with greater 
than 50 CNV calls, because those are more likely to be spuri-
ous calls. The final samples included 1614 esotropia patients 
and 3922 controls. 
CNV Calling 
We used two hidden Markov Model (HMM)-based CNV 
calling algorithms, PennCNV44•45 (version 1.0.4) and Quan-
tiSNP46 (version 2). These algorithms detect CNVs based on 
B allele frequency (BAF) and logR ratio (LRR). We created 
GC wave-adjusted LRR intensity files for all samples using 
PennCNV's genomic_wave.pl script.47 Because HMM algo-
rithms can artificially break up large CNVs, CNV segments 
were merged using PennCNV's clean_cnv.pl script if they 
were of the same copy number and the intervening mark-
ers were less than 20% of the total of both segments. Calls 
from the two programs were merged by taking the intersec-
tion of overlapping calls of the same copy number. Only 
CNVs called by both programs, greater than 10kb, and 
encompassing 10 or more SNPs were included in the final 
call set. 
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F1GUR£ 2. Segmental tests show three significant duplications. 
Manhattan plot of segmental association test results representing 
genome-wide corrected p values calculated at each CNV breakpoint. 
Black circles represent deletions, and gray circles represent dupli-
cations. Three duplications, on chromosomes 2, 4, and 10, were 
significant to P = 1 x 10-6. Toe three circles for chromosome 2 
represent the same duplication, which has different breakpoints in 
different individuals. Some of the indiVidual breakpoints have lower 
Pvalues. 
Call Filtering 
CNVs were filtered out if they overlapped (>50%) with 
regions known to generate artifacts in SNP-based CNV detec-
tion: immunoglobulin domain regions, segmental duplica-
tions, telomeric ends and centromeric regions. We elimi-
nated deletions with a PennCNV confidence score <25 and 
duplications with a PennCNV confidence score < 10. These 
cutoffs were determined empirically based on confirmation 
of CNVs using ddPCR. Several deletions with confidence 
scores <25 were not confirmed by ddPCR, but duplications 
with scores above 10 were confirmed. To limit our dataset 
to rare CNVs, we eliminated CNVs that overlapped (>50%) 
with common CNVs (any CNV with > 10% prevalence in large 
studies compiled by the DECIPHER database or Database of 
Genetic Variants (DGV)). We further eliminated any CNVs 
present in greater than I% of the controls used in this study. 
CNV Annotation 
Rare CNVs were annotated for gene content according to 
RefSeq for the hg19 assembly using PennCNV. 
Association Testing 
We performed I x 106 label-swapping permutations in 
PLINKvl.07 to determine both locus-specific and genome-
wide P values empirically, using the max(1) method.48 In 
the segmental test, case and control frequencies were calcu-
lated at each unique CNV breakpoint. For the gene-based 
test, frequencies were based on the number of genie CNVs 
at each gene locus. Association testing was conducted sepa-
rately for deletions and duplications. 
Removal of Re lated Individuals 
Because recruitment of the esotropia cohort focused on 
patients with affected relatives, some of the participants 
were related. To ensure this was not biasing the results, 
we repeated association testing and per-gene testing after 
removing related individuals. From each family, the individ-
ual with the highest quality control scores was included, and 
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others were excluded. After removing related individuals, 
1379 unrelated esotropic individuals remained. 
Confirmation of CNV s 
Significant CNVs were confirmed using digital droplet 
PCR (ddPCR, BioRad).49 Probes were designed using Bio-
Rad's proprietary algorithm, and the assay was performed 
in duplicate for each patient. Locations of the probes 
were hg19J chr2:87790100-87790222, hg19J chr4:25561415-
25561537, and hg19J chrl0:47100043-47100165 . 
Determination of Insertion Sites 
Whole-genome sequencing (WGS) was performed for three 
individuals with each of the significant CNVs to confirm 
the presence of CNVs and detennine the insertion sites 
and breakpoints. WGS was performed at the Broad Insti-
tute of MIT and Harvard and called against the hg38 refer-
ence genome, which is a single representation of multi-
ple genomes. Results were interpreted by examining read 
depth and split reads at the identified areas using integrated 
genome viewer software and compared to other individuals 
sequenced in the same call set. 
RESULTS 
Esotropia Cohort 
Of the 2030 individuals with esotropia included in the previ-
ous GWAS,21 1614 passed quality control measures for CNV 
calling. This included 851 females and 763 males; 911 from 
the US, 84 from the UK, and 620 from Australia. A total of 224 
had accommodative esotropia, 317 had infantile esotropia, 
and 1075 had nonaccommodative esotropia. 
Rare CNV Burden 
Esotropia patients and controls have similar rates of rare 
CNVs, with approximately 0.8 deletions and 1.1 duplications 
per person. Similar proportions have at least one rare dele-
tion (~54%) or duplication (~62%). Esotropia patients have 
a greater total CNV length: an average of 220.7KB of total 
(rare) deletions, versus 177.8KB in controls (P = 0.007) and 
419.6KB of total (rare) duplications versus 258KB in controls 
(P = 1 x 10-6). The average size of each individual CNV 
was larger in esotropia patients: deletions averaged 151.1 
KB versus 113.2 KB in controls (P = 0.0003) and duplica-
tions averaged 246 KB versus 137.5 KB in controls (P = 
I x 10-6) (Figs. IA, IB). We partitioned across CNV size 
and frequency and calculated odds ratios. Esotropia patients 
were more likely to have a total duplication burden of 500kb-
1MB (OR 1.6, 95% confidence interval [CI] 1.3-1.98, P < 
0.0001) and > 1 MB (odds ratio [OR] 1.6, 95% CI 1.1-2.2, 
P = 0.0109) (Fig. IC) or a total deletion burden > lMB (OR 
1.96, 95% CI 1.16-3.32, P = 0.013; Fig. IE). When combin-
ing deletions and duplications, esotropia cases were more 
likely to have a total CNV burden of 500 kb to 1 MB (OR 
1.3, 95% CI 1.1-1.5, P = 0.0033) or > 1 MB (OR 1.8, 95% CI 
1.4-2.4, P < 0.0001). Esotropia patients showed no increase 
in frequency (number) of duplications (Fig. ID), deletions 
(Fig. IF), or total CNVs. 
Three Rare Recurrent Duplications Confer Risk 
for Esotropia 
To test for enrichment of rare CNVs at individual loci, we 
conducted a segmental genome-wide association test, treat-
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F 1GUR£ 3. Chromosome 2 duplication significantly enriched in esotropia cases. UCSC genome browser plot showing the region of duplication 
on 2pl 1.2 (2:87428677-87965359). Duplications across this region were present in 23 cases (light blue, n indicates number with each set of 
breakpoints) and four controls (dark blue). A nearby deletion was present in one control (dark re([). RefSeq genes are listed underneath. 
Protein coding genes are denoted in blue, lncRNA genes in red, micro RNAs in green, and noncoding RNAs in orange. H3K27 Ac mark 
indicates several putative regulatory regions fall within the duplication. This area is not well conserved over 100 vertebrates, but the genie 
and putative regulatory regions are well conserved in primates and other mammals. TI1e blue ver#cal ltne indicates the position of the 
ddPCR probe used to confirm the duplication. Toe gap in the annotations indicates an unmappable area of the reference genome, usually 
because it is highly repetitive or of low complexity. At bottom are indicated repeats in the region identified by RepeatMasker: SINE, short 
interspersed nuclear elements; LINE, long interspersed nuclear elements; LTR, long terminal repeat elements; DNA, DNA repeat elements; 
SIMPLE, microsatellites, low complexity repeats, satellite repeats, RNA repeats, and other repeats. 
ing deletions and duplications separately. We also conducted 
a complementary gene-based test, conditioned on CNVs 
affecting exons, to account for potentially non-overlapping 
CNVs affecting the same gene. In CNV analysis, in contrast 
to SNP-based GWAS, there is no established P value thresh-
old for genome-wide significance. Therefore we established 
locus-specific and genome-wide corrected P values empiri-
cally through 1,000,000 label-swapping permutations, using 
the max(1) method,48 following the methods of Huang et. 
al.43 Association testing identified three recurrent rare dupli-
cations enriched among esotropia patients that survived 
genome-wide correction for multiple testing (Fig. 2). No 
specific deletions reached genome-wide significance. 
Association testing identified a significant 536kb locus 
on chromosome 2pll.2 (hg19, chr2:87428677-87965359, 
Poorr = 1 x 10- 6), spanning the long noncoding RNA 
(lncRNA) CYTOR, and overlapping microRNAs miR4435-1 
and miR4435·2, which were also identified with the gene-
based test (Pcorr = 1 x 10- 6, 3 x 10- 6 , and 3 x 10- 6 , 
respectively). This CNV was present in 23 cases (1.4%) 
and four controls (0.1%), corresponding to a substantially 
increased esotropia risk (OR 14.16 (95%CI 5.4-38.1)). This 
region contains several putative regulatory regions and has 
areas with conservation among mammals but not other 
vertebrates (Fig. 3). 
A significant 22.8kb locus was identified on chromosome 
4pl5.2 (hg19, chr4:25554332-25577184, Pcorr = 1 x 10- 6), 
spanning exon 1 of the lncRNA LOC101929161, which was 
also identified with the gene-based test (Poorr = 1 x 10- 6). A 
CNV in this location was present in 27 cases (1.7%) and six 
controls (0.2%), corresponding to a substantially increased 
esotropia risk (OR 11.1 (95%CI 4.6-25.2). This region does 
not contain any putative regulatory elements and shows 
conservation with monkeys but not with other animals 
(Fig. 4). 
A significant 654kb locus was identified on chromo-
some lOqll.22 (hg19, chrl0:47049547-47703870, Pcorr = 
1 x 10- 6), spanning the protein-coding genes NPY4R, 
NPY4R2, ANXAB, FA.i',125C, FA.i',125G, AGAP9, and ANTXRL, 
the lncRNA IJNC00842, and pseudogenes HNRNPA1P33, 
BMS1P2, FAM35DP, and ANTX.RLPl, which were all also 
identified with the gene based test (P00rr = 1 x 10- 6, for 
each). A CNV at this locus was present in 64 cases (4.0%) 
and 18 controls (0.4%), corresponding to a substantially 
increased esotropia risk (OR 8.96; 95% CI 5.4- 14.9). Notably, 
the duplication in 36 esotropia cases and O controls spanned 
the full 654 kb, whereas 28 cases and 18 controls had a 
smaller ~300 kb duplication. NPY4R, NPY4R2, LINC00842, 
HNRNPA1P33, ANXAB, FAM25C, FAM25G, AGAP9, and 
BMS1P2 are within the portion of the duplication seen 
only in the esotropia cases. The presence of the smaller 
duplication was associated with an increased esotropia risk 
(OR 3.918; 95%CI 2.2-7.2), indicating that the association is 
not a result of only the larger, extended duplication. The 
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breakpoints) and six controls (dark blue). The duplication includes exon 1 of LOC101929, a Jong noncoding RNA (orange). H3K27Ac marks 
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conservation with nonmammals. The blue vertical line indicates the position of the ddPCR probe used to confirm the duplication. At bottom 
are indicated repeats in the region identified by RepeatMasker: SINE, short interspersed nuclear elements; LINE, long interspersed nuclear 
elements; LTR, Jong terminal repeat elements; DNA, DNA repeat elements; SIMPLE, microsatellites, low complexity repeats, satellite repeats, 
RNA repeats, and other repeats. 
region has several putative regulatory elements but is poorly 
conserved and has multiple repetitive elements (Fig. 5). 
Each of the significant CNVs was validated in affected 
cases by ddPCR. All patients with chromosome 2 and 4 dupli-
cations were validated, and all patients with the larger chro-
mosome 10 duplication were validated, because the probe 
location is within the region unique to esotropia patients. 
Overall, 114 cases (7%) and 28 controls (0.7%) had one of 
the three duplications. No case nor control had more than 
one of the duplications. 
We repeated association testing after removing related 
individuals within the esotropia cohort (see methods), leav-
ing 1379 cases. The same three duplications were again 
significant to P = 1 x 10-6 , by both the breakpoint test 
and gene test, indicating that our results were not driven by 
relatedness of our cases. 
Insertion and Breakpoint Analysis 
To determine whether the duplications were tandem or 
interspersed and to identify the breakpoints, three cases 
with each duplication were chosen for WGS. Sequencing 
all individuals was not feasible, so we chose several unre-
lated individuals with each duplication who harbored differ-
ent predicted breakpoints based on SNP calling. For the 
chromosome 2 duplication we sequenced one infantile and 
two nonaccommodative esotropia participants. For the chro-
mosome 4 duplication we sequenced one accommodative, 
one partially accommodative, and one nonaccommodative 
esotropia participant. For the chromosome 10 duplication 
we sequenced three nonaccommodative esotropia partici-
pants. 
Despite the SNP prediction of different breakpoints, 
the three individuals with the chromosome 4 duplication 
all harbored a tandem duplication with breakpoints at 
chr4:25,554,985 and chr4:25,578,843 (hg38, which corre-
spond to hgl9:chr4:25,556,607 and chr4:25,580,465). Split-
reads were readily identified that span the breakpoints, and 
sequencing coverage was higher across the area of duplica-
tion. Exon 1 of WC101929161 is included in the duplication 
and the breakpoint is just upstream of the exon 2 junction 
(Fig. 6). The chromosome 2 and chromosome 10 duplica-
tions were in areas of the genome with multiple repetitive 
elements and poor mapping of short sequencing reads. We 
therefore could not identify definitive breakpoints for these 
two duplications in these individuals, nor determine whether 
the duplications were tandem or interspersed. 
Esotropia Subtypes 
To determine whether these duplications were associated 
with subtypes of esotropia, we compared the proportion 
of participants in the cohort with accommodative, infantile, 
or nonaccommodative esotropia (as defined above) to the 
proportion with each duplication. In the full cohort, 1075 
(66.5%) participants were classified as nonaccommodative, 
317 (19.6%) as infantile, and 224 (13.9%) as accommoda-
tive. Although the numbers are small, the distribution of 
subtypes differs significantly between the duplications (chi 
square 17.74, degrees of freedom 6, P = 0.0069). Accom-
modative esotropia is underrepresented in patients with the 
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chromosome 2 duplication (only 1 [4%) of individuals 
with the chromosome 2 duplication had accommodative 
esotropia), and absent from patients with the larger chromo-
some 10 duplication. By contrast, accommodative esotropia 
is overrepresented among patients with the chromosome 
4 duplication (eight cases [29.6%) and the smaller chromo-
some 10 duplication (six cases (21.4%) (Fig. 7). 
DISCUSSION 
We demonstrate a role for CNVs in the risk for esotropia, 
a disorder with poorly understood pathophysiology. We 
observe a greater global burden of total rare CNV length, 
and report three recurrent rare duplications that significantly 
increase risk. 
The chromosome 4 duplication includes exon 1 of 
LOC101929161, a lncRNA of unknown function encompass-
ing 4 exons. This RNA is exclusive to primates, with no 
homology in mice. In published RNASeq data, expression 
is primarily in lung and digestive system.50•51 Duplicating 
one exon could alter the conformation of the RNA molecule, 
affecting its affinity for its binding partners. Alternately, the 
duplication could change the 3D chromatin structure, affect-
ing the topographically associated domains and thus regu-
lation of nearby genes. 
The chromosome 2 duplication encompasses one lncRNA 
(CYJ'OR) and two overlapping microRNAs (miR4435-1 and 
miR4435-2). CYfOR is broadly expressed in fetal and adult 
tissues, with low levels in adult and fetal brain,s0 ,s2 and 
is overexpressed in cancer cells.53 The two microRNAs are 
single exons and are presumed to regulate translation of 
other genes. There are no homologous genes or microR-
NAs in mouse. The duplicated region contains multiple puta-
tive regulatory regions, and duplication of these could alter 
expression of their target genes or genes near the insertion 
site. 
The chromosome 10 duplication includes 12 genes, 
of which only a few have known functions. NPY4R and 
NPY4R2 encode neuropeptide Y receptors; neuropeptide 
Y is a gut-brain peptide which modulates multiple phys-
iologic processes, including feeding behavior and anxi-
ety.54 ANXAB encodes annexin 8, one of a family of ea++ 
effector molecules that regulate EGF receptor localization 
and activity.55 ANTXRL, FAM25C, FAM25G, and AGAP9 are 
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F 1GUR£ 6. Breakpoints of chromosome 4 duplication. Whole genome sequences from three unrelated indiViduals with esotropia who harbor 
the chromosome 4 duplication show increased sequence coverage across the duplication and split reads at the breakpoints. Top: Schematic 
of chromosome 4 region of duplication. Middle. Images from integrated genome viewer for each of three indiViduals. Coverage is indicated 
for each base pair by the height of the gray bar, split reads are shown in red and green below. Green reads indicate that the paired read 
maps further away than expected. Bottom: individual reads are shown across the breakpoints. Toe split reads (colored by base-pair that does 
not map to the reference sequence) were mapped back to indicate this is a tandem duplication. TI1e left breakpoint (hg38: 4:25,554,985) is 
just upstream of exon 2 of LOC101929. Toe light breakpoint (hg38: 4:25,578,843) is in an intergenic region. 
protein-coding genes of unknown function. llNC00842 is 
a lncRNA of unknown function. HNRNPA1P33, FAM35DP, 
ANTXRLP1, and BMS1P2 are pseudogenes. 
None of the genes involved in the duplications suggest 
an obvious pathologic mechanism for strabismus, but study 
of their developmental expression patterns and functions 
may lead to further insights into strabismus. The genetic loci 
identified as strabismus risk factors through GWAS, WRB21 
and NPLOC4-TSPAN10-PDE6G,22 similarly do not have obvi-
ous roles in strabismus pathology. 
WGS in three individuals with the chromosome 4 dupli-
cation showed the duplication is tandem and defined the 
breakpoints. Although these individuals are unrelated, the 
breakpoints are identical. These particular breakpoints may 
be a "hotspot" for new duplications, or these individuals may 
share an ancestral haplotype that includes this duplication 
and confers risk for esotropia. 
The breakpoints could not be definitively identified in 
the individuals with chromosome 2 and 10 duplications, 
because the breakpoint regions are in areas of the genome 
with highly repetitive sequence. Mapping reads and identi-
fying split reads in these areas is difficult using short-read 
nex't generation sequencing, because 100 to 150 base pair 
reads of repetitive sequence map to multiple locations in 
the genome. This hinders CNV calling by WGS. By contrast, 
SNP calling uses SNPs present across the region, and these 
CNVs were validated with ddPCR. Unfortunately, repetitive 
genomic areas are those most likely for insertion and dele-
tion events to occur. This is a problem throughout the field 
of genetics, which may be solved in the future by long read 
sequencing. 
A limitation of using publicly available control datasets 
is that individuals with strabismus, especially a history of 
treated childhood strabismus, may be included in our control 
set. This, however, strengthens our findings , because some 
of the control individuals with these duplications may have 
strabismus. Similarly, strabismus patients may be included in 
public databases of "healthy" individuals, making compar-
isons to public databases of CNVs difficult to interpret. DGV 
reports structural variation present in healthy individuals, 
from studies that called CNVs using differing algorithms and 
genotyping platforms. A similar duplication on chromosome 
4 has a frequency of 0.34% in DGV,56 similar to the 0.2% rate 
in our controls. On chromosomes 2 and 10, somewhat larger 
duplications have frequencies of 1.58% and 1.74%, respec-
tively, much higher than in our control population (0.2% 
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20% infantile (dark grtzy stripes), and 66% nonaccommoclative, noninfantile (black). Accommodative esotropia is underrepresented in the 
chromosome 2 and larger chromosome 10 duplications, and overrepresented in the chromosome 4 duplication. P = 0.069, chi square. 
Numbers of participants in each group are provided in the table. 
and 0.4%). This may reflect differences in CNV calling algo-
rithms and genotyping platforms, quality control measures, 
or populations included. Using these control frequencies, the 
chromosome 10 duplication remains significant whereas the 
chromosome 2 duplication does not. Because our cases and 
controls were called using identical parameters, they provide 
a more valid comparison. 
Although we have one of the largest and most accurately 
phenotyped esotropia cohorts, it remains underpowered to 
detect extremely rare CNVs or those of moderate effect. 
Although we show an association between these rare dupli-
cations and esotropia subtypes, our numbers are too small to 
draw definitive conclusions. Whether these duplications are 
more prevalent in exotropia, indicating a genetic predispo-
sition to strabismus generally, rather than esotropia specifi-
cally, remains to be explored. 
Large CNVs cause many genetic syndromes that include 
strabismus, including Down syndrome (duplication chro-
mosome 21),57- 59 Williams-Beuren syndrome (deletion 
7qll.23),60 and deletion of 10q26.61 CNVs have also been 
reported in patients with Duane syndrome, a form of para-
lytic strabismus.62 Interestingly, large (>5Mb) duplications of 
IOqll, which encompass the 654kb region we report, cause 
IOq duplication syndrome which includes developmental 
delay, dysmorphic features, and, in 5/8 cases, strabismus.63 
A male with a 4.5Mb duplication of 4pl5.2, which encom-
passes the 23kb duplication we report here, was reported 
to have developmental delay, congenital heart disease and 
strabismus.64 The participants in this study all had nonsyn-
dromic strabismus, and there are no specific syndromes 
associated with the precise duplications we identified. 
We provide here the first evidence that CNVs contribute 
to genetic risk in nonsyndromic esotropia. Further research 
into the functional consequences of these duplications will 
hopefully increase our understanding of the pathophysiol-
ogy of strabismus. 
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